{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,1,30]],"date-time":"2025-01-30T06:14:49Z","timestamp":1738217689702,"version":"3.34.0"},"reference-count":30,"publisher":"Springer Science and Business Media LLC","license":[{"start":{"date-parts":[[2008,4,18]],"date-time":"2008-04-18T00:00:00Z","timestamp":1208476800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Z. Rheumatol."],"DOI":"10.1007\/s00393-008-0288-3","type":"journal-article","created":{"date-parts":[[2008,4,16]],"date-time":"2008-04-16T11:37:09Z","timestamp":1208345829000},"source":"Crossref","is-referenced-by-count":3,"title":["Leberwerterh\u00f6hung bei rheumatoider Arthritis","Elevated liver enzymes in rheumatoid arthritis"],"prefix":"10.1007","author":[{"given":"U.","family":"Hartmann","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"S.","family":"Schmitt","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"M.","family":"Reuss-Borst","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2008,4,18]]},"reference":[{"key":"288_CR1","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1177\/106002809603000110","volume":"30","author":"Alderman","year":"1996","unstructured":"Alderman CP (1996) Adverse effects of the angiotensin-converting enzyme inhibitors. Ann Pharmacother 30: 55\u201361","journal-title":"Ann Pharmacother"},{"key":"288_CR2","doi-asserted-by":"crossref","first-page":"1095","DOI":"10.1080\/00365520510023846","volume":"40","author":"Bj\u00f6rnsson","year":"2005","unstructured":"Bj\u00f6rnsson E, Jerlstad P, Bergqvist A, Olsson R (2005) Fulminant drug-induced hepatic failure leading to death or liver transplantation in Sweden. Scand J Gastroenterol 40: 1095\u20131101","journal-title":"Scand J Gastroenterol"},{"key":"288_CR3","doi-asserted-by":"crossref","first-page":"295","DOI":"10.1016\/j.rdc.2004.01.010","volume":"30","author":"Cannon","year":"2004","unstructured":"Cannon GW, Kremer JM (2004) Leflunomide. Rheum Dis Clin North Am 30: 295\u2013309","journal-title":"Rheum Dis Clin North Am"},{"key":"288_CR4","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1136\/adc.87.4.293","volume":"87","author":"Davison","year":"2002","unstructured":"Davison S (2002) Coeliac disease and liver dysfunction. Arch Dis Child 87: 293\u2013296","journal-title":"Arch Dis Child"},{"key":"288_CR5","doi-asserted-by":"crossref","first-page":"1308","DOI":"10.1055\/s-2004-826865","volume":"129","author":"Dechant","year":"2004","unstructured":"Dechant C, Schauenberg P, Antoni CE et al. (2004) Langzeitergebnisse einer TNF-Blockade beim Morbus Still im Erwachsenenalter. DMW 129: 1308\u20131312","journal-title":"DMW"},{"key":"288_CR6","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1136\/bmj.306.6872.233","volume":"306","author":"Fairley","year":"1993","unstructured":"Fairley CK, McNeil JJ, Desmond P et al. (1993) Risk factors for development of flucloxacillin associated jaundice. BMJ 306: 233\u2013235","journal-title":"BMJ"},{"key":"288_CR7","unstructured":"Gause AM, Sch\u00f6ning C (2007) Manifestation einer auoimmunen Lebererkrankung unter Adalimumab. Z Rheumatol (Suppl) 1: 54"},{"key":"288_CR8","doi-asserted-by":"crossref","first-page":"1519","DOI":"10.1136\/ard.2004.032821","volume":"64","author":"Germano","year":"2005","unstructured":"Germano V, Picchianti Diamanti A, Baccano G et al. (2005) Autoimmune hepatitis associated with infliximab in a patient with psoriatic arthritis. Ann Rheum Dis 64: 1519\u20131520","journal-title":"Ann Rheum Dis"},{"key":"288_CR9","first-page":"292","volume":"8","author":"Hartleb","year":"2002","unstructured":"Hartleb M, Biernat L, Kochel A (2002) Drug-induced liver damage a three-year study of patients from one gastroenterological department. Med Sci Monit 8: 292\u2013296","journal-title":"Med Sci Monit"},{"key":"288_CR10","doi-asserted-by":"crossref","first-page":"234","DOI":"10.1007\/s10067-002-0689-7","volume":"22","author":"Iwai","year":"2003","unstructured":"Iwai M, Harada Y, Ishii M et al. (2003) Autoimmune hepatitis in a patient with systemic lupus erythematosus. Clin Rheumatol 22: 234\u2013236","journal-title":"Clin Rheumatol"},{"key":"288_CR11","doi-asserted-by":"crossref","first-page":"73","DOI":"10.2169\/internalmedicine.39.73","volume":"39","author":"Katayama","year":"2000","unstructured":"Katayama Y, Kohriyama K, Kirizuka K et al. (2000) Sj\u00f6gren\u2019s syndrome complicated with autoimmune hepatitis and antiphospholipid antibody syndrome. Intern Med 39: 73\u201376","journal-title":"Intern Med"},{"key":"288_CR12","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1111\/j.1600-0676.1994.tb00079.x","volume":"14","author":"Koek","year":"1994","unstructured":"Koek GH, Stricker BH, Blok AP et al. (1994) Flucloxacillin-associated hepatic injury. Liver 14: 225\u2013229","journal-title":"Liver"},{"key":"288_CR13","doi-asserted-by":"crossref","first-page":"447","DOI":"10.1016\/S0149-2918(04)90048-3","volume":"26","author":"Li","year":"2004","unstructured":"Li EK, Tam LS, Tomlinson B (2004) Leflunomide in the treatment of rheumatoid arthritis. Clin Ther 26: 447\u2013459","journal-title":"Clin Ther"},{"key":"288_CR14","doi-asserted-by":"crossref","first-page":"509","DOI":"10.1111\/j.1872-034X.2007.00289.x","volume":"Res","author":"Lohse","year":"2007","unstructured":"Lohse AW, Hennes E (2007) Diagnostic criteria for autoimmune hepatitis. Hepatol Res (Suppl 3) 37: 509","journal-title":"Hepatol"},{"key":"288_CR15","doi-asserted-by":"crossref","first-page":"434","DOI":"10.1016\/S0025-6196(24)00530-5","volume":"55","author":"Ludwig","year":"1980","unstructured":"Ludwig J, Viggiano TR, McGill DB, Oh BJ (1980) Nonalcoholic steatohepatitis: Mayo Clinic experiences with a hitherto unnamed disease. Mayo Clin Proc 55: 434\u2013438","journal-title":"Mayo Clin Proc"},{"key":"288_CR16","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1097\/00000478-200404000-00006","volume":"28","author":"Misdraji","year":"2004","unstructured":"Misdraji J, Thiim M, Graeme-Cook FM (2004) Autoimmune hepatitis with centrilobular necrosis. Am J Surg Pathol 28: 471\u2013478","journal-title":"Am J Surg Pathol"},{"key":"288_CR17","doi-asserted-by":"crossref","unstructured":"Ramos-Casals M, Brito-Zer\u00f3n P, Munoz S et al. (2007) Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases. Medicine (Baltimore) 86: 242\u2013251","DOI":"10.1097\/MD.0b013e3181441a68"},{"key":"288_CR18","doi-asserted-by":"crossref","first-page":"1650","DOI":"10.1002\/hep.21949","volume":"46","author":"Rubio-Tapia","year":"2007","unstructured":"Rubio-Tapia A, Murray JA (2007) The liver in celiac disease. Hepatology 46: 1650\u20131658","journal-title":"Hepatology"},{"key":"288_CR19","doi-asserted-by":"crossref","first-page":"76","DOI":"10.1111\/j.1365-2125.2005.02370.x","volume":"60","author":"Russmann","year":"2005","unstructured":"Russmann S, Kaye JA, Jick SS, Jick H (2005) Risk of cholestatic liver disease associated with flucloxacillin and flucloxacillin prescribing habits in the UK: cohort study using data from the UK General Practice Research Database. Br J Clin Pharmacol 60: 76\u201382","journal-title":"Br J Clin Pharmacol"},{"key":"288_CR20","doi-asserted-by":"crossref","first-page":"637","DOI":"10.1517\/14740338.4.4.637","volume":"4","author":"Scheinfeld","year":"2005","unstructured":"Scheinfeld N (2005) Adalimumab: a review of side effects. Expert Opin Drug Saf 4: 637\u2013641","journal-title":"Expert Opin Drug Saf"},{"key":"288_CR21","doi-asserted-by":"crossref","first-page":"335","DOI":"10.2169\/internalmedicine.44.335","volume":"44","author":"Sema","year":"2005","unstructured":"Sema K, Takei M, Uenogawa K et al. (2005) Felty\u2019s syndrome with chronic hepatitis and compatible autoimmune hepatitis: a case presentation. Intern Med 44: 335\u2013341","journal-title":"Intern Med"},{"key":"288_CR22","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1007\/s10067-005-0169-y","volume":"26","author":"Tobon","year":"2007","unstructured":"Tobon GJ, Canas C, Jaller JJ et al. (2007) Serious liver disease induced by infliximab. Clin Rheumatol 26: 578\u2013581","journal-title":"Clin Rheumatol"},{"key":"288_CR23","doi-asserted-by":"crossref","first-page":"701","DOI":"10.5694\/j.1326-5377.1989.tb139652.x","volume":"151","author":"Turner","year":"1989","unstructured":"Turner IB, Eckstein RP, Riley JW, Lunzer MR (1989) Prolonged hepatic cholestasis after flucloxacillin therapy. Med J Aust 151: 701\u2013705","journal-title":"Med J Aust"},{"key":"288_CR24","doi-asserted-by":"crossref","first-page":"1168","DOI":"10.1136\/ard.2003.009563","volume":"62","author":"Putte","year":"2003","unstructured":"Putte LBA van de, Rau R, Breedveld FC et al. (2003) Efficacy and safety of the fully human anti-tumour necrosis factor \u03b1 monoclonal antibody adalimumab (D2E7) in DMARD refractory patients with rheumatoid arthritis: a 12 week, phase II study. Ann Rheum Dis 62: 1168\u20131177","journal-title":"Ann Rheum Dis"},{"key":"288_CR25","doi-asserted-by":"crossref","unstructured":"Wiegand J, M\u00f6ssner J, Tillmann HL (2007) Non-alcoholic fatty liver disease and non-alcoholic steatohepatitis. Internist (Berl) 48: 154\u2013163","DOI":"10.1007\/s00108-006-1796-3"},{"key":"288_CR26","doi-asserted-by":"crossref","first-page":"26","DOI":"10.1007\/s00393-005-0701-0","volume":"64","author":"Wiegard","year":"2005","unstructured":"Wiegard C, Lohse AW (2005) Leber und Rheuma. Z Rheumatol 64: 26\u201331","journal-title":"Z Rheumatol"},{"key":"288_CR27","doi-asserted-by":"crossref","first-page":"1130","DOI":"10.1007\/s00535-005-1711-z","volume":"40","author":"Yatsuji","year":"2005","unstructured":"Yatsuji S, Hashimoto E, Kaneda H et al. (2005) Diagnosing autoimmune hepatitis in nonalcoholic fatty liver disease: is the International Autoimmune Hepatitis Group scoring system useful? J Gastroenterol 40: 1130\u20131138","journal-title":"J Gastroenterol"},{"key":"288_CR28","doi-asserted-by":"crossref","first-page":"1493","DOI":"10.5858\/2003-127-1493-RH","volume":"127","author":"Yeung","year":"2003","unstructured":"Yeung E, Wong FS, Wanless IR et al. (2003) Ramipril-associated hepatotoxicity. Arch Pathol Lab Med 127: 1493\u20131497","journal-title":"Arch Pathol Lab Med"},{"key":"288_CR29","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1097\/00004836-200210000-00012","volume":"35","author":"Youssef","year":"2002","unstructured":"Youssef WI, Tavill AS (2002) Connective tissue diseases and the liver. J Clin Gastroenterol 35: 345\u2013349","journal-title":"J Clin Gastroenterol"},{"key":"288_CR30","doi-asserted-by":"crossref","first-page":"1148","DOI":"10.1007\/s00535-005-1713-x","volume":"40","author":"Zeniya","year":"2005","unstructured":"Zeniya M, Watanabe F, Morizane T et al. (2005) Diagnosing clinical subsets of autoimmune liver diseases based on a multivariable model. J Gastroenterol 40: 1148\u20131154","journal-title":"J Gastroenterol"}],"container-title":["Zeitschrift f\u00fcr Rheumatologie"],"original-title":[],"language":"de","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0288-3.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00393-008-0288-3\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00393-008-0288-3","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,1,29]],"date-time":"2025-01-29T19:19:25Z","timestamp":1738178365000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00393-008-0288-3"}},"subtitle":["Differenzialdiagnostische \u00dcberlegungen an einem Fallbeispiel","Differential diagnostic considerations based on a case report"],"short-title":[],"issued":{"date-parts":[[2008,4,18]]},"references-count":30,"alternative-id":["288"],"URL":"https:\/\/doi.org\/10.1007\/s00393-008-0288-3","relation":{},"ISSN":["0340-1855","1435-1250"],"issn-type":[{"type":"print","value":"0340-1855"},{"type":"electronic","value":"1435-1250"}],"subject":[],"published":{"date-parts":[[2008,4,18]]}}}